PTC Therapeutics, Inc. (PTCT)

SEC filing

PTC Therapeutics, Inc.

PTCT · CIK 1070081

4 · Nov 19, 2025 · Boulding Mark Elliott sold 2,812 shares at $75.99/share ($213.7K); exercised options for 2,812 shares

Boulding Mark Elliott sold 2,812 shares at $75.99/share ($213.7K); exercised options for 2,812 shares

xslF345X05/form4-11192025_051101.xml

xslF345X05/form4-11192025_051101.xmlSEC.gov

Graphics and non-inline formats (not embedded below).